Successful allogeneic hematopoietic stem cell transplantation for AML with pulmonary mucormycosis under isavuconazole

This publication has 30 references indexed in Scilit:

• A Pharmacokinetic Bioequivalence Study Comparing Different‐Strength and ‐Size Capsules of Isavuconazonium Sulfate in Healthy Japanese Subjects
  Clinical Pharmacology in Drug Development, 2022
• Surgical resection for persistent localized pulmonary fungal infection prior to allogeneic hematopoietic stem cell transplantation: Analysis of six cases
  Journal of Infection and Chemotherapy, 2020
• Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
  The Lancet Infectious Diseases, 2019
• Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
  The Lancet Infectious Diseases, 2016
• Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
  The Lancet, 2016
• Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
  Transplantation and Cellular Therapy, 2014
• Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
  Clinical Infectious Diseases, 2007
• Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
  Clinical Infectious Diseases, 2005
• Stem cell transplantation post invasive fungal infection is a feasible task
  American Journal of Hematology, 2003
• Pulmonary mucormycosis: Results of medical and surgical therapy
  The Annals of Thoracic Surgery, 1994